We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
- Authors
Fanale, Michelle; Fayad, Luis; Pro, Barbara; Samaniego, Felipe; Liboon, Mary Joy; Nunez, Cesar; Horowitz, Sandra; Anderlini, Paolo; Popat, Uday; Ji, Yuan; Kwak, Larry W.; Younes, Anas
- Abstract
The article offers information on Classical Hodgkin lymphoma (HL). It discusses the causes for the development of relapsed or refractory disease in the patients. The treatment for Hodgkin lymphoma through bortezomib plus ifosfamide, carboplatin, etoposide (BICE) has also been discussed in the article.
- Subjects
HODGKIN'S disease treatment; LYMPHOMAS; ANTINEOPLASTIC agents; ETOPOSIDE; PATHOLOGY
- Publication
British Journal of Haematology, 2011, Vol 154, Issue 2, p284
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/j.1365-2141.2011.08618.x